| |
 |
| |
|
|
| |
| |
|
|
 |
The blood-brain barrier: a challenge for CNS drug discovery
Joan Abbott
|
|
[
Modem ]
[
DSL ]
|
|
 |
| |
|
|
|
The utility of biomarkers in CNS R&D
Vincenzo Libri
|
|
[
Modem ]
[
DSL ]
|
|
|
| |
|
|
|
In vivo strategies to select compounds with clinical efficacy
Thomas Rosahl
|
|
[
Modem ]
[
DSL ]
|
|
|
| |
|
|
|
In-vitro strategies to select compounds with clinical efficacy.
Lars E. Sundstrom
|
|
[
Modem ]
[
DSL ]
|
|
|
| |
|
|
|
CNS disorders and their treatment: progress and prospects
Paul Whiting
|
|
[
Modem ]
[
DSL ]
|
|
|
| |
|
|
|
The contribution of neuroimaging to CNS drug discovery
Steve Williams
|
|
[
Modem ]
[
DSL ]
|
|
|
| |
|
|
|
Strategies for the identification and validation of new CNS drug targets
Chas Bountra
|
|
[
Modem ]
[
DSL ]
|
|
|
